Cargando…
Injectable cardiac tissue engineering for the treatment of myocardial infarction
Heart disease is a leading cause of morbidity and mortality worldwide. Myocardial infarction leads to permanent loss of cardiac tissue and ultimately heart failure. However, current therapies could only stall the progression of the disease. Thus, new therapies are needed to regenerate damaged hearts...
Autores principales: | Wang, Haibin, Zhou, Jin, Liu, Zhiqiang, Wang, Changyong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3822739/ https://www.ncbi.nlm.nih.gov/pubmed/20193036 http://dx.doi.org/10.1111/j.1582-4934.2010.01046.x |
Ejemplares similares
-
Current status of induced pluripotent stem cells in cardiac tissue regeneration and engineering
por: Liu, Zhiqiang, et al.
Publicado: (2013) -
Cardiac Tissue Engineering for the Treatment of Myocardial Infarction
por: Yu, Dongmin, et al.
Publicado: (2021) -
Injectable biodegradable hydrogels for embryonic stem cell transplantation: improved cardiac remodelling and function of myocardial infarction
por: Wang, Haibin, et al.
Publicado: (2012) -
Injectable Hydrogels for Cardiac Tissue Repair after Myocardial Infarction
por: Hasan, Anwarul, et al.
Publicado: (2015) -
Engineered heart tissue graft derived from somatic cell nuclear transferred embryonic stem cells improve myocardial performance in infarcted rat heart
por: Lü, Shuanghong, et al.
Publicado: (2010)